Skip to content
Screener

Bausch + Lomb BLCO Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$10.1B-1.6%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$266.4M-2.8%
Glaukos logo
GlaukosGKOS
$32.43M+5.4%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$815K+32.3%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$909K+531%
AbbVie logo
AbbVieABBV
$34.11B+9.4%

Other financials

Income statement

See full
Revenue$1.4B+9.1%
Operating income$83.0M+855%
Net income-$14.0M+77.4%
EPS (diluted)-$0.04+77.8%

Balance sheet

See full
Cash & equivalents$378.0M+39.0%
Total debt$5.1B+2.4%
Total equity$6.4B-1.0%
Total assets$13.9B+0.2%

Cash flow

See full
Operating cash flow$153.0M+337%
CapEx$71.0M-20.2%
Free cash flow$82.0M+252%

Valuation

See full
Market cap$5.84B+17.0%
Enterprise value$10.54B+8.9%
P/S1.1×+0.1×

Profitability

See full
Operating margin6.1%+5.3pp
Net margin-3.2%-1.0pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-2.7%-0.7pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The source filing: Bausch + Lomb’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:17 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001860742-26-000088
Line itemJune 30, 2026December 31, 2025
Current portion of long-term debt and other financial liabilities4339
Total current liabilities1,8901,920
Deferred tax liabilities, net1819
Other non-current liabilities435521
Long-term debt and other financial liabilities5,0725,043
Total liabilities7,4157,503
Commitments and contingencies (Note 16)
Equity

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch + Lomb's other non-current liabilities?
Bausch + Lomb (BLCO) reported other non-current liabilities of $435M in Q2 2026.
How has Bausch + Lomb's other non-current liabilities changed year-over-year?
Bausch + Lomb's other non-current liabilities decreased by 19.3% year-over-year, from $539M to $435M.
What is the long-term trend for Bausch + Lomb's other non-current liabilities?
Over 4 years (2021 to 2025), Bausch + Lomb's other non-current liabilities has grown at a 15.0% compound annual growth rate (CAGR), from $298M to $521M.
What does other non-current liabilities mean?
Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.

Ask your AI about Bausch + Lomb's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude